Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancer

7 Apr 2021

Abstract excerpt

BACKGROUND: Two promising therapeutic strategies in oncology are chimeric antigen receptor-T cell (CAR-T) therapies and antibody-drug conjugates (ADCs). To be effective and safe, these immunotherapies require surface antigens to be sufficiently expressed in tumors and less or not expressed in normal tissues. To identify new targets for ADCs and CAR-T specifically targeting breast cancer (BC) molecular and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33838601
DOI: 10.1016/j.esmoop.2021.100102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancerPMID 33838601Read ↗

The Target Atlas for Antibody-Drug Conjugates across Solid CancersSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine developmentSemantic proximity Read ↗

Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis.Semantic proximity Read ↗

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancerSemantic proximity Read ↗

Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients.Semantic proximity Read ↗

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypesSemantic proximity Read ↗

Identification of novel tumor antigens and immune subtypes in breast cancer patients for mRNA vaccine developmentSemantic proximity Read ↗

Machine learning analysis identifies genes differentiating triple negative breast cancersSemantic proximity Read ↗

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast CancerSemantic proximity Read ↗

Identification of subtype recognition and prognosis model characterized by Antibody-dependent cell phagocytosis related genes in breast cancerSemantic proximity Read ↗

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerSemantic proximity Read ↗

Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug ConjugatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.